ASHP guidelines on preventing medication errors with chemotherapy and biotherapy

Barry Goldspiel1, James M Hoffman1, Niesha L Griffith1

  • 1Barry Goldspiel, Pharm.D., BCPS, BCOP, FASHP, FISOPP, is Chief, Clinical Pharmacy Specialist Section, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD. James M. Hoffman, Pharm.D., M.S., BCPS, is Medication Outcomes and Safety Officer, Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. Niesha L. Griffith, M.S., FASHP, is Director of Pharmacy and Infusion Services, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus. Susan Goodin, Pharm.D., BCOP, FASHP, FCCP, is Executive Director, Statewide Affairs, Rutgers Cancer Institute of New Jersey, New Brunswick, and Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, New Brunswick. Robert DeChristoforo, M.S., FASHP, is Chief, Clinical Center Pharmacy Department, National Institutes of Health. CAPT Michael Montello, Pharm.D., M.B.A., is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant, Clinical Investigations Branch, National Cancer Institute (NCI) Cancer Therapy Evaluation Program, Bethesda, and Project Officer, NCI Cancer Trials Support Unit, Bethesda. Judy L. Chase, Pharm.D., FASHP, is Director, Clinical Pharmacy Services, University of Texas M. D. Anderson Cancer Center, Houston. Sylvia Bartel, M.P.H., is Director of Pharmacy and Clinical Support Services, Dana-Farber Cancer Institute, Boston, MA. Jharana Tina Patel, Pharm.D., is Quality Assurance Officer, Clinical Center, National Institutes of Health.

Summary

No abstract available in PubMed .

Related Concept Videos

Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.7K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
102
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
3.3K
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
2.7K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K